Investor Presentaiton
Some figures at transition OBS (cont'd)
Level of SHE
Level of CSM
AXA
CNP Assurances
Generali
€58b excl. OCI (vs. €58b
excl. OCI)
~€20b (vs €21.1b)
€32b (vs. €32b)
€34b gross of tax (€25b
Life, €9b Health)
-€17b
-€33b
Great-West Lifeco
HISCOX
€3b
No quantitative disclosure
No quantitative disclosure
No quantitative disclosure
16% (vs. 26%)
Decrease of 10%-15%
No quantitative disclosure
No quantitative disclosure
No quantitative disclosure
Decrease by low single-digits
No quantitative disclosure
16% -17% (vs. 14%-15%)
No quantitative disclosure
$2.5b at HY22
No quantitative disclosure
No quantitative disclosure
No quantitative disclosure
No quantitative disclosure
$2.6b at HY22
No quantitative disclosure
22% at 4021
CSM release duration
Risk adjustment
Expected operating profit
Expected revenue
Expected to be 9%-11% per
annum for L&S, 6%-8% for
Health
€3b-€4b
Similar; no quantitative
disclosure
Approx. 12% per annum
8%-10%
~€1.5b
ROE
No quantitative disclosure
No change to 13 %-15%
target
No quantitative disclosure
No quantitative disclosure
No quantitative disclosure
Financial leverage ratio
19%-23% (vs. 25%-28%)
No quantitative disclosure
20
Market updates on impact of IFRS 17 and IFRS 9
EYView entire presentation